Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.

Source:http://linkedlifedata.com/resource/pubmed/id/16361622

J. Clin. Oncol. 2005 Dec 20 23 36 9250-6

Download in:

View as

Triples

General Info

PMID
16361622